RAP 0.00% 20.5¢ resapp health limited

Though they have signed deals with telehealth providers, it does...

  1. 418 Posts.
    lightbulb Created with Sketch. 28
    Though they have signed deals with telehealth providers, it does not have any material impact to the company revenue. There is no revenue growth in the quarterly that could justify the value of this company in the event of a scheme fail. The board is in favour of the scheme, I don't see how they will fulfil the future vision of this company unless the whole board management is getting replaced. In this circumstance and with a capital raise to maintain ongoing operating costs, the SP will fall back to low 5c and have to start from the beginning. It will take years to crawl back to what the prosposed 14.5c is. There are other risk opportunities to invest elsewhere that we will miss out if insist to stay on with this company.
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.